205 related articles for article (PubMed ID: 21448164)
1. CpG-island methylation study of liver fluke-related cholangiocarcinoma.
Sriraksa R; Zeller C; El-Bahrawy MA; Dai W; Daduang J; Jearanaikoon P; Chau-In S; Brown R; Limpaiboon T
Br J Cancer; 2011 Apr; 104(8):1313-8. PubMed ID: 21448164
[TBL] [Abstract][Full Text] [Related]
2. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
[TBL] [Abstract][Full Text] [Related]
4. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.
Lee S; Kim WH; Jung HY; Yang MH; Kang GH
Am J Pathol; 2002 Sep; 161(3):1015-22. PubMed ID: 12213730
[TBL] [Abstract][Full Text] [Related]
5. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.
Thanasai J; Limpaiboon T; Jearanaikoon P; Bhudhisawasdi V; Khuntikeo N; Sripa B; Miwa M
World J Gastroenterol; 2006 Jul; 12(27):4338-44. PubMed ID: 16865775
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.
Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T
Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468
[TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
Uhm KO; Lee ES; Lee YM; Kim HS; Park YN; Park SH
Oncol Res; 2008; 17(4):151-7. PubMed ID: 18773859
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.
Chusorn P; Namwat N; Loilome W; Techasen A; Pairojkul C; Khuntikeo N; Dechakhamphu A; Talabnin C; Chan-On W; Ong CK; Teh BT; Yongvanit P
Tumour Biol; 2013 Jun; 34(3):1579-88. PubMed ID: 23417858
[TBL] [Abstract][Full Text] [Related]
9. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
10. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
11. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.
Muenphon K; Limpaiboon T; Jearanaikoon P; Pairojkul C; Sripa B; Bhudhisawasdi V
World J Gastroenterol; 2006 Jul; 12(26):4143-8. PubMed ID: 16830362
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.
Limpaiboon T; Khaenam P; Chinnasri P; Soonklang M; Jearanaikoon P; Sripa B; Pairojkul C; Bhudhisawasdi V
Cancer Lett; 2005 Jan; 217(2):213-9. PubMed ID: 15617839
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors.
Sriraksa R; Zeller C; Dai W; Siddiq A; Walley AJ; Limpaiboon T; Brown R
Cancer Prev Res (Phila); 2013 Dec; 6(12):1348-55. PubMed ID: 24089088
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.
Liengswangwong U; Karalak A; Morishita Y; Noguchi M; Khuhaprema T; Srivatanakul P; Miwa M
World J Gastroenterol; 2006 Jun; 12(23):3740-5. PubMed ID: 16773692
[TBL] [Abstract][Full Text] [Related]
15. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma.
Liang J; Liu T; Liao J; Zhang L; Zhou M; Xu W; He Y; Cai G; Jin G; Song J; Li G; Liang H; Ding Z; Zhang B
J Cell Physiol; 2021 Apr; 236(4):3143-3156. PubMed ID: 32996133
[TBL] [Abstract][Full Text] [Related]
17. Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell.
Khaenam P; Niibori A; Okada S; Jearanaikoon P; Araki N; Limpaiboon T
Asian Pac J Cancer Prev; 2012; 13(8):4007-11. PubMed ID: 23098508
[TBL] [Abstract][Full Text] [Related]
18. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
19. Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma.
Amornpisutt R; Sriraksa R; Limpaiboon T
Clin Biochem; 2012 Sep; 45(13-14):1092-4. PubMed ID: 22569599
[TBL] [Abstract][Full Text] [Related]
20. DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.
Dachrut S; Banthaisong S; Sripa M; Paeyao A; Ho C; Lee SA; Kosinski C; Patil MA; Zhang J; Chen X; Sripa B; Pairojkul C
Asian Pac J Cancer Prev; 2009; 10(4):575-82. PubMed ID: 19827872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
